Foster Inhaler 100/6MCG Indications
Foster Inhaler 100/6MCG is primarily indicated in conditions like Acute gout, Acute spasm and spasm in diagnostic procedures, Ankylosing spondylitis, Benign gastric and duodenal ulceration, Duodenal ulceration, Gout, Juvenile chronic arthritis, Musculoskeletal disorders, Nausea and vomiting (palliative care), Osteoarthritis, Pain, Resistant oedema, Rheumatoid arthritis.
The severe or irreversible adverse effects of Foster Inhaler 100/6MCG, which give rise to further complications include Skin reactions, Erythema.,Foster Inhaler 100/6MCG produces potentially life-threatening effects which include Gl bleeding, Aplastic Anemia, Renal damage, Peptic ulceration, Purpura, Pemphigus vulagris. which are responsible for the discontinuation of Foster Inhaler 100/6MCG therapy., The signs and symptoms that are produced after the acute overdosage of Foster Inhaler 100/6MCG include Nausea, Vomiting, Diarrhea, Hematuria, GI disturbances, Renal failure, GI hemorrhage, Proteinuria, Hypoprothrombinemia., The symptomatic adverse reactions produced by Foster Inhaler 100/6MCG are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Palpitation, Insomnia, Confusion, Vertigox, Hearing loss, Mood swings, Paresthesias, Hypoglycemia.
Foster Inhaler 100/6MCG is contraindicated in conditions like Peptic ulcer,Thrombosis,Impaired hepatic function.
Foster Inhaler 100/6MCG should be used with caution in patients with intrinsic coagulation defects and those on anticoagulant therapy. It should be used with caution in patients with compromised cardiac function. hypertension other condition predisposing to fluid retention. It should be used with extra care in the presence of existing controlled infection. Perform periodic auditory function test during chronic therapy. Discontinue drug if skin reaction occurs.